Showing 41 - 60 results of 178 for search '"Boosterism"', query time: 0.05s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49

    One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic by Ondrej Šušol, Barbora Šušolová, Ondřej Klempíř, Milan Navrátil, Jaromír Gumulec, Zdeněk Kořístek, Juraj Ďuraš, Michal Kaščák, Jana Mihályová, Lukáš Stejskal, Tomáš Jelínek, Petra Richterová, Lenka Szeligová, Hana Plonková, Jana Zuchnická, Barbora Dluhošová, Ivo Demel, David Buffa, Katarína Hradská, Tereza Popková, Ludmila Muroňová, Martin Lachnit, Klára Lančová, Roman Hájek

    Published 2024-12-01
    “…We have seen better results if the time interval between anti‐CD20 therapy and additional vaccine dose was longer than 6 months (5/8 patients achieved seroconversion on 4th booster dose after previous failure). Also, 36 patients received a 4th dose of vaccine as a booster with measurable increase in protective antibodies in 50% (18/36). …”
    Get full text
    Article
  10. 50
  11. 51
  12. 52
  13. 53

    Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study by Alane Izu, Eleanora Aml Mutsaerts, Courtney Olwagen, Lisa Jose, Anthonet Koen, Amit J Nana, Clare L. Cutland, Shabir A. Madhi

    Published 2025-12-01
    “…Background Due to high costs of pneumococcal conjugate vaccines (PCV), transitioning from a two (2 + 1) to a single dose (1 + 1) primary series with a booster should be considered. This study evaluated the immune response at 18 months of age following a 1 + 1 compared to a 2 + 1 schedule of 10-valent (PCV10) and 13-valent (PCV13) vaccines.Research design and methods A single-center, open-label, randomized trial conducted in Soweto, South Africa, evaluated the immunogenicity of differing dosing schedule for PCV10 and PCV13. …”
    Get full text
    Article
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58

    The concept of reducing the man-made impact of launches of the promising Irtysh launch vehicle in the impact areas of the Baikonur cosmodrome by B. T. Suimenbayev, V. I. Trushlyakov, G. T. Yermoldina, Zh. B. Suimenbayeva, A. M. Bapyshev

    Published 2019-06-01
    “…The basic directions for reducing the anthropogenic impact of the spent booster of the first stage of the «Irtysh» type LV in the areas of falling are: determination of optimal areas for the spent booster to fall in selected areas of the FA with the highest stability and minimum cost of works on restoring the soil state — (A); controlled descent of the spent booster after separation from the LV to the designated section of the fall with an accuracy not exceeding the size of the selected optimal section — (B). …”
    Get full text
    Article
  19. 59

    Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vacci... by Dandan Peng, Tingmei Zhao, Weiqi Hong, Minyang Fu, Cai He, Li Chen, Wenyan Ren, Hong Lei, Jingyun Yang, Aqu Alu, Yanghong Ni, Jian Liu, Jiong Li, Wei Wang, Guobo Shen, Zhiwei Zhao, Li Yang, Jinliang Yang, Zhenling Wang, Yoshimasa Tanaka, Guangwen Lu, Xiangrong Song, Xiawei Wei

    Published 2023-04-01
    “…In light of such situation, the vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is in desperate need of the third booster. It has been reported that heterologous boosters might produce more effective immunity against wild‐type SARS‐CoV‐2 and the variants. …”
    Get full text
    Article
  20. 60

    Solutions without Space-Time Separation for ADS Experiments: Overview on Developments and Applications by B. Merk, V. Glivici-Cotruţă

    Published 2012-01-01
    “…The SC3A experiment in the YALINA-Booster facility is described and investigated. For this investigation the very special configuration of YALINA-Booster is analyzed based on HELIOS calculations. …”
    Get full text
    Article